Literature DB >> 1995477

Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely.

E P van der Esch1, C S Muir, J Nectoux, G Macfarlane, P Maisonneuve, H Bharucha, J Briggs, R A Cooke, A G Dempster, W B Essex.   

Abstract

To assess whether the increase in malignant melanoma incidence could be due, at least in part, to changes in histological criteria of malignancy, pathologists in Australia, France, Italy, New Zealand, Norway, Sweden, the United Kingdom, the United States and the USSR reviewed diagnoses of 50 consecutive pigmented naevi (40 junctional and compound; 10 intradermal) and 20 consecutive malignant melanomas made in each participating centre around 1930, around 1955 and around 1980. Collaborating pathologists re-read the material, 2,665 cases in all, either from the original slide (82%) or from a recut block (17%), gave their diagnosis and indicated whether the lesion was benign (B), dubious benign (DB), dubious malignant (DM) or malignant (M). As the distribution of review diagnoses was much the same whether the original slide or one made from a recut block was read, the material was pooled. Overall, 2.8% of cases originally reported as B/DB were reviewed as DM/M, while 4.4% of the DM/M diagnoses were held to be B/DB. The shifts between categories were greatest around 1955 and least around 1980, suggesting increasing uniformity of interpretation. All available blocks were recut and sections sent to IARC for review: 1.7% (22) of 1293 B/DB diagnoses were considered to be DM/M and 3.3% (18) of 551 DM/M diagnoses were considered to have been B/DB. The consistently low frequency of shift in diagnostic category, whether the material was reviewed in the collaborating laboratories or by one pathologist at IARC, in a study designed to give maximum attention to those lesions--the junctional and compound naevi--in which a change in opinion as to malignancy would be most likely to arise, suggests that pathologists, irrespective of geographical location, are using common criteria. These findings argue against changes in histological interpretation as being responsible for more than a small portion of the continuous increase of some 3% to 8% per annum observed in malignant melanoma incidence. Other explanations, such as an increase in the frequency or potential for malignant transformation of precursor lesions, must be sought. The anatomical distribution of the malignant melanomas examined followed the usual site pattern by sex, and their thickness was observed to decrease over the period of the study in most centres.

Entities:  

Mesh:

Year:  1991        PMID: 1995477     DOI: 10.1002/ijc.2910470402

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel.

Authors: 
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

2.  Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry.

Authors:  Alan C Geller; Richard W Clapp; Arthur J Sober; Lou Gonsalves; Lloyd Mueller; Cindy L Christiansen; Waqas Shaikh; Donald R Miller
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

3.  Melanoma: linked temporal and latitude changes in the United States.

Authors:  J A Lee; J Scotto
Journal:  Cancer Causes Control       Date:  1993-09       Impact factor: 2.506

4.  Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site.

Authors:  Y T Chen; T Zheng; T R Holford; M Berwick; R Dubrow
Journal:  Cancer Causes Control       Date:  1994-07       Impact factor: 2.506

Review 5.  Current melanoma epidemic: a nonmetastasizing form of melanoma?

Authors:  R C Burton; B K Armstrong
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

6.  13. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010.

Authors:  D M Parkin; D Mesher; P Sasieni
Journal:  Br J Cancer       Date:  2011-12-06       Impact factor: 7.640

7.  Trends in cancer incidence and mortality in Scotland: description and possible explanations.

Authors:  A J Swerdlow; I dos Santos Silva; A Reid; Z Qiao; D H Brewster; J Arrundale
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

8.  Survival from melanoma of the skin in England and Wales up to 2001.

Authors:  B Rachet; M J Quinn; N Cooper; M P Coleman
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

9.  Trends in mortality rates from malignant melanoma in Sweden 1953-1987 and forecasts up to 2007.

Authors:  M Thörn; P Sparén; R Bergström; H O Adami
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

10.  Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden.

Authors:  M Thörn; F Pontén; R Bergström; P Sparén; H O Adami
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.